← Back to Search

Caregiver Support Groups for Psychological Distress (SoCalSavvy Trial)

N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests two programs designed to help caregivers of people with dementia. One program has fewer sessions, and the other has more. Both aim to teach caregivers better skills and provide emotional support through group meetings.

Who is the study for?
This trial is for English-speaking adults aged 18 or older in Southern California who are caring for someone with dementia. It's not suitable for caregivers with sensory or physical conditions that prevent them from participating in group activities.
What is being tested?
The study compares two versions of the Savvy Caregiver Program: a shorter, 3-week version called Savvy Caregiver Express™ and the original, longer 6-week program. The effectiveness will be measured immediately after, at 3 months and at 6 months post-intervention.
What are the potential side effects?
Since this trial involves educational group sessions rather than medical treatments, there are no direct side effects like those associated with medications. However, participants may experience emotional discomfort discussing their experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Generalized Anxiety Disorder (GAD-7)
Patient Health Questionnaire-9 (PHQ-9)
Revised Memory and Behavior Problems Checklist (RMBPC)
Secondary study objectives
Caregiver Competence Scales
Family Members Activities of Daily Living (ADL)
Family Members Instrumental Activities of Daily Living (IADL)
+2 more
Other study objectives
Caregiver Satisfaction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Savvy ExpressActive Control1 Intervention
Savvy Express, 3 weekly sessions, group treatment, addressing educational, informational, and psychosocial issues and community resources.
Group II: Savvy Caregiver ProgramActive Control1 Intervention
Savvy Caregiver Program, 6 weekly sessions, group treatment, addressing educational, informational, and psychosocial issues and community resources.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Caregiver training and support programs, such as Savvy Caregiver Express™ and Savvy Caregiver Program, work by providing structured training sessions that equip caregivers with practical skills and knowledge to manage caregiving tasks more effectively. These programs also offer emotional support and coping strategies to handle stress. By enhancing caregivers' competence and reducing feelings of isolation, these interventions can significantly alleviate burnout. This is crucial for Caregiver Burnout patients as it directly addresses the root causes of their stress, improving their well-being and the quality of care they provide.

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
944 Previous Clinical Trials
1,604,524 Total Patients Enrolled

Media Library

Group sessions over 3 weeks Clinical Trial Eligibility Overview. Trial Name: NCT04421729 — N/A
Caregiver Burnout Research Study Groups: Savvy Express, Savvy Caregiver Program
Caregiver Burnout Clinical Trial 2023: Group sessions over 3 weeks Highlights & Side Effects. Trial Name: NCT04421729 — N/A
Group sessions over 3 weeks 2023 Treatment Timeline for Medical Study. Trial Name: NCT04421729 — N/A
~23 spots leftby Nov 2025